長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【4530】久光製薬

【4530】久光製薬
製薬。鎮痛消炎剤。大衆薬も。
類似企業：
【業界1位】 小野薬品工業
【売上同水準】 日本新薬 杏林製薬


東証プライム
医薬
＞
医他
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2025.02 2024/10/10 Q2予 152,000 → 0.0% 0.0% 14,500 → 0.0% 0.0% 18,900 → 0.0% 0.0% 15,800 → 0.0% 0.0%
2025.02 2024/07/11 Q1予 152,000 → 0.0% 0.0% 14,500 → 0.0% 0.0% 18,900 → 0.0% 0.0% 15,800 → 0.0% 0.0%
2025.02 2024/04/11 当初予 152,000 - - - 14,500 - - - 18,900 - - - 15,800 - - -
2024.02 2024/04/11 実 141,706 ↑ +0.5% +7.1% 13,167 ↓ -8.6% +11.6% 19,649 ↓ -1.3% +34.6% 13,969 ↓ -4.3% +31.8%
2024.02 2024/01/11 Q3予 141,000 ↑ +6.6% +6.6% 14,400 ↑ +22.0% +22.0% 19,900 ↑ +36.3% +36.3% 14,600 ↑ +37.7% +37.7%
2024.02 2023/10/06 Q2予 132,300 → 0.0% 0.0% 11,800 → 0.0% 0.0% 14,600 → 0.0% 0.0% 10,600 → 0.0% 0.0%
2024.02 2023/07/13 Q1予 132,300 → 0.0% 0.0% 11,800 → 0.0% 0.0% 14,600 → 0.0% 0.0% 10,600 → 0.0% 0.0%
2024.02 2023/04/13 当初予 132,300 - - - 11,800 - - - 14,600 - - - 10,600 - - -
2023.02 2023/04/13 実 128,330 ↑ +0.0% +4.3% 11,599 ↑ +0.9% +4.5% 16,051 ↑ +0.3% +26.4% 11,742 ↓ -2.1% +21.1%
2023.02 2023/03/30 修正予 128,300 ↑ +4.3% +4.3% 11,500 ↑ +3.6% +3.6% 16,000 ↑ +26.0% +26.0% 12,000 ↑ +23.7% +23.7%
2023.02 2023/01/12 Q3予 123,000 → 0.0% 0.0% 11,100 → 0.0% 0.0% 12,700 → 0.0% 0.0% 9,700 → 0.0% 0.0%
2023.02 2022/10/12 Q2予 123,000 → 0.0% 0.0% 11,100 → 0.0% 0.0% 12,700 → 0.0% 0.0% 9,700 → 0.0% 0.0%
2023.02 2022/07/07 Q1予 123,000 → 0.0% 0.0% 11,100 → 0.0% 0.0% 12,700 → 0.0% 0.0% 9,700 → 0.0% 0.0%
2023.02 2022/04/07 当初予 123,000 - - - 11,100 - - - 12,700 - - - 9,700 - - -
2022.02 2022/04/07 実 120,193 ↑ +0.2% -2.2% 9,337 ↑ +0.4% -12.7% 12,638 ↑ +0.3% -0.5% 9,658 ↑ +3.8% -2.4%
2022.02 2022/03/23 修正予 120,000 ↓ -2.4% -2.4% 9,300 ↓ -13.1% -13.1% 12,600 ↓ -0.8% -0.8% 9,300 ↓ -6.1% -6.1%
2022.02 2022/01/13 Q3予 122,900 → 0.0% 0.0% 10,700 → 0.0% 0.0% 12,700 → 0.0% 0.0% 9,900 → 0.0% 0.0%
2022.02 2021/10/14 Q2予 122,900 → 0.0% 0.0% 10,700 → 0.0% 0.0% 12,700 → 0.0% 0.0% 9,900 → 0.0% 0.0%
2022.02 2021/07/08 Q1予 122,900 → 0.0% 0.0% 10,700 → 0.0% 0.0% 12,700 → 0.0% 0.0% 9,900 → 0.0% 0.0%
2022.02 2021/04/08 当初予 122,900 - - - 10,700 - - - 12,700 - - - 9,900 - - -
2021.02 2021/04/08 実 114,510 ↓ -0.4% -9.8% 10,671 ↑ +0.7% -17.3% 11,829 ↓ -0.6% -20.1% 9,250 ↓ -0.5% -12.7%
2021.02 2021/03/23 修正予 115,000 ↓ -9.4% -9.4% 10,600 ↓ -17.8% -17.8% 11,900 ↓ -19.6% -19.6% 9,300 ↓ -12.3% -12.3%
2021.02 2021/01/13 Q3予 127,000 → 0.0% 0.0% 12,900 → 0.0% 0.0% 14,800 → 0.0% 0.0% 10,600 → 0.0% 0.0%
2021.02 2020/10/08 Q2予 127,000 → 0.0% 0.0% 12,900 → 0.0% 0.0% 14,800 → 0.0% 0.0% 10,600 → 0.0% 0.0%
2021.02 2020/07/09 当初予 127,000 - - - 12,900 - - - 14,800 - - - 10,600 - - -
2020.02 2020/04/10 実 140,992 ↓ -1.7% -1.7% 22,727 ↓ -0.8% -0.8% 25,628 ↑ +0.5% +0.5% 18,694 ↓ -3.6% -3.6%
2020.02 2020/01/10 Q3予 143,500 → 0.0% 0.0% 22,900 → 0.0% 0.0% 25,500 → 0.0% 0.0% 19,400 → 0.0% 0.0%
2020.02 2019/10/10 Q2予 143,500 → 0.0% 0.0% 22,900 → 0.0% 0.0% 25,500 → 0.0% 0.0% 19,400 → 0.0% 0.0%
2020.02 2019/07/10 Q1予 143,500 → 0.0% 0.0% 22,900 → 0.0% 0.0% 25,500 → 0.0% 0.0% 19,400 → 0.0% 0.0%
2020.02 2019/04/10 当初予 143,500 - - - 22,900 - - - 25,500 - - - 19,400 - - -
2019.02 2019/04/10 実 143,408 ↓ -3.4% -3.4% 22,278 ↓ -7.2% -7.2% 24,647 ↓ -6.3% -6.3% 19,204 ↑ +0.0% +0.0%
2019.02 2019/01/11 Q3予 148,500 → 0.0% 0.0% 24,000 → 0.0% 0.0% 26,300 → 0.0% 0.0% 19,200 → 0.0% 0.0%
2019.02 2018/10/10 Q2予 148,500 → 0.0% 0.0% 24,000 → 0.0% 0.0% 26,300 → 0.0% 0.0% 19,200 → 0.0% 0.0%
2019.02 2018/07/06 Q1予 148,500 → 0.0% 0.0% 24,000 - - - 26,300 → 0.0% 0.0% 19,200 → 0.0% 0.0%
2019.02 2018/04/10 当初予 148,500 - - - - - - - 26,300 - - - 19,200 - - -
2018.02 2018/04/10 実 - - - - - - - - - - - - - - - -
2018.02 2018/03/28 修正予 148,000 ↑ +0.7% +0.7% - - - - 28,400 ↑ +10.9% +10.9% 19,200 ↑ +3.8% +3.8%
2018.02 2018/01/12 Q3予 147,000 → 0.0% 0.0% 24,100 → 0.0% 0.0% 25,600 → 0.0% 0.0% 18,500 → 0.0% 0.0%
2018.02 2017/10/10 Q2予 147,000 → 0.0% 0.0% 24,100 → 0.0% 0.0% 25,600 → 0.0% 0.0% 18,500 → 0.0% 0.0%
2018.02 2017/07/07 Q1予 147,000 → 0.0% 0.0% 24,100 → 0.0% 0.0% 25,600 → 0.0% 0.0% 18,500 → 0.0% 0.0%
2018.02 2017/04/07 当初予 147,000 - - - 24,100 - - - 25,600 - - - 18,500 - - -
2017.02 2017/04/07 実 145,925 ↓ -5.9% -5.9% 26,306 ↓ -6.1% -6.1% 28,179 ↓ -2.8% -2.8% 20,395 ↑ +5.1% +5.1%
2017.02 2017/01/13 Q3予 155,000 → 0.0% 0.0% 28,000 → 0.0% 0.0% 29,000 → 0.0% 0.0% 19,400 → 0.0% 0.0%
2017.02 2016/10/11 Q2予 155,000 → 0.0% 0.0% 28,000 → 0.0% 0.0% 29,000 → 0.0% 0.0% 19,400 → 0.0% 0.0%
2017.02 2016/04/08 当初予 155,000 - - - 28,000 - - - 29,000 - - - 19,400 - - -
2016.02 2016/04/08 実 161,852 ↓ -1.5% -1.5% 27,730 ↑ +1.2% +1.2% 28,008 ↓ -1.7% -1.7% 17,784 ↓ -2.8% -2.8%
2016.02 2016/01/08 Q3予 164,300 → 0.0% 0.0% 27,400 → 0.0% 0.0% 28,500 → 0.0% 0.0% 18,300 → 0.0% 0.0%
2016.02 2015/10/09 Q2予 164,300 → 0.0% 0.0% 27,400 → 0.0% 0.0% 28,500 → 0.0% 0.0% 18,300 → 0.0% 0.0%
2016.02 2015/07/10 Q1予 164,300 → 0.0% 0.0% 27,400 - - - 28,500 → 0.0% 0.0% 18,300 → 0.0% 0.0%
2016.02 2015/04/08 当初予 164,300 - - - - - - - 28,500 - - - 18,300 - - -
2015.02 2015/04/08 実 - - - - - - - - - - - - - - - -
2015.02 2015/01/09 Q3予 161,900 → 0.0% 0.0% 20,400 → 0.0% 0.0% 27,800 → 0.0% 0.0% 18,000 → 0.0% 0.0%
2015.02 2014/10/09 Q2予 161,900 → 0.0% 0.0% 20,400 → 0.0% 0.0% 27,800 → 0.0% 0.0% 18,000 → 0.0% 0.0%
2015.02 2014/10/02 修正予 - - - - - - - - - - - - - - - -
2015.02 2014/07/10 Q1予 161,900 → 0.0% 0.0% 20,400 → 0.0% 0.0% 27,800 → 0.0% 0.0% 18,000 → 0.0% 0.0%
2015.02 2014/04/10 当初予 161,900 - - - 20,400 - - - 27,800 - - - 18,000 - - -
2014.02 2014/04/10 実 150,635 - - - 19,123 - - - 28,910 - - - 21,357 - - -
シェア ツイート
ページトップへ戻る